LARS Antibody

Leucyl-tRNA synthetase (LARS) catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. LARS exhibits a post-transfer editing activity to hydrolyze mischarged tRNAs [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/Q9P2J5].
LARS
leucyl-tRNA synthetase
Leucine--tRNA ligase, cytoplasmic
:  cytoplasmic leucyl-tRNA synthetase cytosolic leucyl-tRNA synthetase FLJ10595 FLJ21788 hr025Cl HSPC192 ILFS1 LARS1 leucine translase leucine tRNA ligase 1, cytoplasmic Leucyl-tRNA synthetase LEURS LEUS LFIS LRS PIG44 proliferation-inducing gene 44 RNTLS
Product
Specifications
Ordering Information
Human, Mouse
WB
Between 1 to 50
$339
$229
$99
Human, Mouse
WB, IHC
Between 250 to 300
$339
$229
$99
Human, Mouse
WB, IP, IHC
Includes: 1 each of A304-315A and A304-316A
$472
Includes: 1 each of A304-315A and A304-316A